Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Term Efficacy of Triamcinolone Acetonide in Atopic Dermatitis
NCT05844618Phase 4Completed
- Sponsor
- Innovaderm Research
- Start
- May 2023
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in atopic dermatitis (AD), sponsored by Innovaderm Research. Started May 2023; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05844618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05844618.